Browsing Tag
ustekinumab
7 posts
FDA accepts first biosimilar without clinical efficacy studies: Will this redefine global biologics access?
FDA waives efficacy trials for Stelara biosimilar, opening new doors for fast-track biosimilar access. Find out how this could reshape drug affordability worldwide.
Biocon Biologics reports positive Phase 3 results for Yesintek, biosimilar to Ustekinumab
Biocon Biologics Ltd., a global leader in biosimilar medicines and a subsidiary of India’s pioneering biopharmaceutical giant Biocon…
Bio-Thera Solutions and Tabuk Pharmaceuticals partner to bring BAT2206 to Saudi Arabia
Bio-Thera Solutions Inc., a Chinese biopharmaceutical company, has announced a strategic partnership with Tabuk Pharmaceutical Manufacturing Company, a…
EMA accepts MAA for Dong-A ST’s Stelara biosimilar, DMB-3115
Dong-A ST, the South Korean pharmaceutical company, has received confirmation from the European Medicine Agency (EMA) of the…
Biocon Biologics signs licensing deal for two biosimilars with Yoshindo
Biocon Ltd. said that its subsidiary Biocon Biologics has signed an out-licensing agreement with Japanese pharma company Yoshindo…
Bio-Thera, Hikma Pharmaceuticals sign $150m licensing deal for BAT2206
Chinese biopharma company Bio-Thera Solutions has signed a commercialization and license deal worth up to $150 million with…
Janssen bags Stelara FDA approval for ulcerative colitis treatment
Stelara FDA approval for ulcerative colitis treatment : The Janssen Pharmaceutical Companies of Johnson & Johnson has bagged…